Growth Metrics

Pfizer (PFE) Minority Interest (2016 - 2025)

Pfizer (PFE) has disclosed Minority Interest for 17 consecutive years, with $299.0 million as the latest value for Q4 2025.

  • Quarterly Minority Interest rose 1.7% to $299.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $299.0 million through Dec 2025, up 1.7% year-over-year, with the annual reading at $299.0 million for FY2025, 1.7% up from the prior year.
  • Minority Interest for Q4 2025 was $299.0 million at Pfizer, up from $295.0 million in the prior quarter.
  • The five-year high for Minority Interest was $317.0 million in Q2 2025, with the low at $227.0 million in Q4 2022.
  • Average Minority Interest over 5 years is $273.8 million, with a median of $273.5 million recorded in 2021.
  • Peak annual rise in Minority Interest hit 19.74% in 2021, while the deepest fall reached 21.47% in 2021.
  • Over 5 years, Minority Interest stood at $262.0 million in 2021, then dropped by 2.29% to $256.0 million in 2022, then grew by 7.03% to $274.0 million in 2023, then rose by 7.3% to $294.0 million in 2024, then grew by 1.7% to $299.0 million in 2025.
  • According to Business Quant data, Minority Interest over the past three periods came in at $299.0 million, $295.0 million, and $317.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.